Exane Derivatives Portfolio Holdings

Exane Derivatives

  • $157 Million
  • Q2 2022

Exane Derivatives has filed its 13F form on July 12, 2022 for Q2 2022 where it was disclosed a total value porftolio of $157 Million distributed in 758 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Spdr S&P 500 ETF Trust with a value of $8.79M, Microsoft Corp with a value of $6.17M, Merck & Co., Inc. with a value of $5.92M, Cameco Corp with a value of $5.21M, and Ishares Inc Msci Global Select with a value of $3.52M.

Examining the 13F form we can see an decrease of $167M in the current position value, from $323M to 157M. Also it can be appreciated an additional of 57 stocks purchases and 316 closed positions.

Below you can find more details about Exane Derivatives portfolio as well as his latest detailed transactions.

Portfolio value $157 Million
ETFs: $28.2 Million
Technology: $25.8 Million
Healthcare: $20.9 Million
Energy: $19.3 Million
Industrials: $11.4 Million
Consumer Defensive: $10.7 Million
Financial Services: $10.4 Million
Consumer Cyclical: $10.2 Million
Other: $19.7 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$0
$8.79 Million 5.61% of portfolio
23,297
Q2 2022 Reduced 21.04%
$0
$3.52 Million 2.25% of portfolio
98,754
Q2 2022 Reduced 35.24%
$0
$3.44 Million 2.19% of portfolio
61,556
Q2 2022 Reduced 34.64%
$0
$2.98 Million 1.9% of portfolio
35,530
Q2 2022 New
$0
$2.63 Million 1.68% of portfolio
9,371
Q2 2022 Added 48.65%
$0
$1.46 Million 0.93% of portfolio
28,968
Q2 2022 Reduced 1.81%
$0
$1.11 Million 0.71% of portfolio
8,138
Q2 2022 Reduced 17.07%
$0
$552,000 0.35% of portfolio
13,736
Q2 2022 Reduced 37.54%
$0
$525,000 0.34% of portfolio
5,185
Q2 2022 Added 84.19%
$0
$508,000 0.32% of portfolio
4,974
Q2 2022 Reduced 19.41%
$83.5B
$494,000 0.32% of portfolio
2,935
Q2 2022 Reduced 71.44%
$0
$245,000 0.16% of portfolio
3,170
Q2 2022 Reduced 36.22%
$0
$257,000 0.16% of portfolio
13,559
Q4 2021 Added 22,881.36%
$0
$209,000 0.13% of portfolio
2,581
Q1 2022 Added 1.1%
$0
$185,000 0.12% of portfolio
2,720
Q1 2022 Added 18.88%
$0
$185,000 0.12% of portfolio
9,969
Q2 2022 Reduced 1.77%
$1.66B
$178,000 0.11% of portfolio
7,720
Q2 2022 Added 22.23%
$0
$158,000 0.1% of portfolio
6,945
Q2 2022 Reduced 74.88%
$0
$136,000 0.09% of portfolio
507
Q2 2022 New
$0
$130,000 0.08% of portfolio
374
Q2 2022 New
$0
$128,000 0.08% of portfolio
6,310
Q1 2022 Added 52,483.33%
$0
$71,000 0.05% of portfolio
425
Q1 2022 Reduced 74.02%
$0
$35,000 0.02% of portfolio
611
Q2 2022 Reduced 85.69%
$0
$21,000 0.01% of portfolio
464
Q1 2022 Added 9.95%
$14.1B
$14,000 0.01% of portfolio
799
Q1 2022 Reduced 83.35%
$0
$21,000 0.01% of portfolio
901
Q1 2022 Added 10.01%
$0
$8,000 0.01% of portfolio
66
Q2 2022 Reduced 90.91%
$0
$0 0.0% of portfolio
294
Q2 2022 Reduced 98.5%
$0
$0 0.0% of portfolio
1,250
Q1 2022 New
$0
$0 0.0% of portfolio
90
Q2 2022 Reduced 99.29%
$0
$0 0.0% of portfolio
10
Q4 2021 Reduced 99.69%
$0
$0 0.0% of portfolio
6,963
Q2 2022 Added 623.05%
$0
$0 0.0% of portfolio
2
Q1 2022 Reduced 99.99%
$0
$0 0.0% of portfolio
31
Q2 2021 Reduced 99.0%
$0
$0 0.0% of portfolio
2,000
Q2 2021 New
$0
$0 0.0% of portfolio
500
Q1 2022 Reduced 60.63%
$0
$0 0.0% of portfolio
4
Q1 2019 Reduced 94.37%
$0
$0 0.0% of portfolio
3
Q2 2022 Reduced 99.96%
$0
$0 0.0% of portfolio
5
Q2 2022 New
$0
$0 0.0% of portfolio
291
Q1 2022 Added 11.07%
$0
$0 0.0% of portfolio
762
Q2 2022 Reduced 98.73%
$0
$0 0.0% of portfolio
4,580
Q2 2022 Reduced 25.31%
$0
$0 0.0% of portfolio
10,164
Q2 2022 Added 78.22%
$0
$1,000 0.0% of portfolio
89
Q3 2021 Reduced 94.96%
$0
$0 0.0% of portfolio
900
Q2 2022 New
$0
$0 0.0% of portfolio
1,460
Q1 2022 Reduced 96.0%
$0
$0 0.0% of portfolio
389
Q2 2022 Added 8.96%
$0
$5,000 0.0% of portfolio
70
Q2 2022 Reduced 96.49%
$0
$0 0.0% of portfolio
6
Q2 2022 Reduced 99.91%

Summary

  • Portfolio
  • No. of Stocks 758
  • Current Value $157 Million
  • Prior Value $323 Million
  • Filing
  • Period Q2 2022
  • Filing Date July 12, 2022
  • Form Type 13F-HR
  • Activity in Q2 2022
  • New Purchases 57 stocks
  • Additional Purchases 90 stocks
  • Sold out of 316 stocks
  • Reduced holdings in 353 stocks
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email